F. Grand’Maison

Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis

Tomáš Kalinčík, Dana Horáková, Tim Spelman et al. · Annals of Neurology · 2014 · 157 citations · Full text

<scp>BREMSO</scp>: a simple score to predict early the natural course of multiple sclerosis

Roberto Bergamaschi, Cristina Montomoli, Giulia Mallucci et al. · European Journal of Neurology · 2015 · 40 citations

Minimum Standards for Electromyography in Canada: A Statement of the Canadian Society of Clinical Neurophysiologists

C F Bolton, Tim J Benstead, F. Grand’Maison et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2000 · 31 citations

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

Tim Spelman, Linda Mekhael, Therese Burke et al. · European Journal of Neurology · 2016 · 22 citations · Full text

Tolerability and Safety of Combined Glatiramer Acetate and N-Acetylcysteine in Relapsing-Remitting Multiple Sclerosis

Hyman M. Schipper, Douglas L. Arnold, F. Grand’Maison et al. · Clinical Neuropharmacology · 2015 · 12 citations